Next-Gen IVD LC-MS/MS System 5X More Sensitive for Quantifying Analytes in Saliva, Breath and Dried Blood Spots
By LabMedica International staff writers Posted on 06 Apr 2023 |
As energy expenses increase dramatically and laboratory spaces remain in high demand, the need for an analytical instrument that can perform complex trace analyte quantification and increase in-house testing while also reducing energy consumption and saving lab space has become critical. Now, an extremely compact and sustainable analytical instrument accurately quantifies trace analytes with outstanding precision. This powerful instrument can improve patient care, generate cost savings, and meet a laboratory's unique analytical workflow requirements with its vast array of customizable options.
Waters Corporation (Milford, MA, USA) has introduced its next-generation Xevo TQ Absolute IVD mass spectrometer, expanding its family of MassTrak IVD LC-MS/MS Systems for clinical diagnostic applications. The new MassTrak LC-MS/MS IVD system now comprises the ACQUITY UPLC I-Class PLUS liquid chromatography instrument and the Xevo TQ Absolute IVD mass spectrometer. The ACQUITY UPLC I-Class PLUS System is designed to provide fast and precise sample analysis to improve mass spectrometer sensitivity and simplify complex sample characterization. The Xevo TQ Absolute IVD System is more consistent than other tandem quadrupole-mass spectrometry (TQ-MS) systems, with a user-friendly design that maximizes service uptime. Additionally, it is 45% smaller and uses 50% less nitrogen gas and electricity than comparable TQ-MS systems, making it ideal for hospital and commercial labs seeking to reduce energy consumption and save space.
The Xevo TQ Absolute IVD mass spectrometer offers exceptional analytical performance, with up to five times greater sensitivity for quantifying clinical analytes compared to other commercial instruments available. This heightened sensitivity allows clinical laboratories to detect and measure trace-level analytes within a sample, reaching detection levels previously unattainable. This capability expands the testing capabilities of clinical laboratories, making it possible to work with lower volume samples obtained from less invasive assays such as saliva, breath, and dried blood spots. Additionally, the system empowers clinical laboratories to expand their test menu to include multiplex panels and large molecules.
“Waters’ MassTrak IVD systems gives clinical diagnostic laboratories highly precise and flexible options that ultimately enable clinicians to provide better patient care,” said Jianqing Bennett, Waters Corporation Senior Vice President of the Waters Clinical Business Unit. “Adding the Xevo TQ Absolute IVD to the MassTrak IVD family offers customers class-leading sensitivity and analytical performance. Waters is uniquely positioned to enable clinical laboratories to develop reliable test methods for difficult analytes, helping them expand their capabilities to manage emerging remote sampling techniques.”
Related Links:
Waters Corporation
Latest Clinical Chem. News
- 3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models
- POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection
- Highly Reliable Cell-Based Assay Enables Accurate Diagnosis of Endocrine Diseases
- New Blood Testing Method Detects Potent Opioids in Under Three Minutes
- Wireless Hepatitis B Test Kit Completes Screening and Data Collection in One Step
- Pain-Free, Low-Cost, Sensitive, Radiation-Free Device Detects Breast Cancer in Urine
- Spit Test Detects Breast Cancer in Five Seconds
- Electrochemical Sensors with Next-Generation Coating Advances Precision Diagnostics at POC
- First-Of-Its-Kind Handheld Device Accurately Detects Fentanyl in Urine within Seconds
- New Fluorescent Sensor Array Lights up Alzheimer’s-Related Proteins for Earlier Detection
- Automated Mass Spectrometry-Based Clinical Analyzer Could Transform Lab Testing
- Highly Sensitive pH Sensor to Aid Detection of Cancers and Vector-Borne Viruses
- Non-Invasive Sensor Monitors Changes in Saliva Compositions to Rapidly Diagnose Diabetes
- Breakthrough Immunoassays to Aid in Risk Assessment of Preeclampsia
- Urine Test for Monitoring Changes in Kidney Health Markers Can Predict New-Onset Heart Failure
- AACC Releases Comprehensive Diabetes Testing Guidelines